Woodline Partners’s Nanobiotix NBTX Stock Holding History

Woodline Partners’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,009	Closed	-$49K	–	800
2022 Q2	$49K	Sell	13,009 -4,279	-25%	-$23K	﹤0.01%	641
2022 Q1	$121K	Sell	17,288 -25,284	-59%	-$200K	﹤0.01%	566
2021 Q4	$345K	Sell	42,572 -9,063	-18%	-$88.7K	﹤0.01%	569
2021 Q3	$587K	Sell	51,635 -8,359	-14%	-$112K	0.01%	541
2021 Q2	$827K	Sell	59,994 -4,520	-7%	-$70.7K	0.02%	446
2021 Q1	$970K	Sell	64,514 -5,486	-8%	-$94.2K	0.02%	373
2020 Q4	$1.16M	Buy	+70,000	New	+$1.21M	0.03%	208

Other funds holding NBTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Woodline Partners's NBTX Position: Q3 2022 in Review

Woodline Partners sold out of Nanobiotix (NBTX) in Q3 2022, closing a stake of 13,009 shares — an estimated $49K sold.

Woodline Partners first reported a position in NBTX in Q4 2020 and held it in 7 quarters. The position peaked at $1.16M in Q4 2020. 5 funds tracked by Wall St. Rank hold NBTX as of Q3 2022.

Woodline Partners reported no remaining Nanobiotix position as of Q3 2022 after selling out during the quarter.
Woodline Partners sold 13,009 Nanobiotix shares in Q3 2022, an estimated $49K.
Woodline Partners first reported a position in Nanobiotix in Q4 2020 and held it in 7 quarters.
Woodline Partners's Nanobiotix position peaked at $1.16M in Q4 2020.
5 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2022.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.